Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lipton

Showing results (1021-1030 of 1,173) with videos related to

Pageof 118
Sort By:
Frontiers in Neurology|March 13, 2023
Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION-A phase 4, multinational, randomized, double-blind, placebo-controlled studyRigmor H Jensen, Henrik Winther Schytz, Cristina Tassorelli, et al.
Cephalalgia : an International Journal of Headache|June 14, 2023
Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and careAubrey Manack Adams, Dawn C Buse, Elizabeth Leroux, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 29, 2022
The Spanish-English bilingual experience and cognitive change in Hispanics/Latinos from the Hispanic Community Health Study/Study of Latinos-Investigation of Neurocognitive AgingMelissa Lamar, Wassim Tarraf, Benson Wu, et al.
Neurology|August 28, 2024
Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME TrialRichard B Lipton, Andrea M Harriott, Julia Y Ma, et al.
Headache|May 24, 2024
Machine learning identifies factors most associated with seeking medical care for migraine: Results of the OVERCOME (US) studySait Ashina, E Jolanda Muenzel, Robert A Nicholson, et al.
Cephalalgia : an International Journal of Headache|September 15, 2021
Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trialTodd J Schwedt, Richard B Lipton, Jessica Ailani, et al.
Headache|September 8, 2022
Short-term stroke risk after emergency department treat-and-release headache visitAva L Liberman, Cenai Zhang, Richard B Lipton, et al.
Cephalalgia : an International Journal of Headache|June 22, 2011
The International Burden of Migraine Study (IBMS): study design, methodology, and baseline cohort characteristicsKrista A Payne, Sepideh F Varon, Ariane K Kawata, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Reference Data of the Spanish Memory Binding Test in a Midlife Population from the ALFA STUDY (Alzheimer's and Family)Nina Gramunt, Herman Buschke, Gonzalo Sánchez-Benavides, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 1, 1992
Genetic, immunological, and metabolic determinants of risk for type 1 diabetes mellitus in familiesR B Lipton, J Atchison, J S Dorman, et al.
Pageof 118

Showing results (1021-1030 of 1,173) with videos related to

Sort By:
Pageof 118
Frontiers in Neurology|March 13, 2023
Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION-A phase 4, multinational, randomized, double-blind, placebo-controlled studyRigmor H Jensen, Henrik Winther Schytz, Cristina Tassorelli, et al.
Cephalalgia : an International Journal of Headache|June 14, 2023
Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and careAubrey Manack Adams, Dawn C Buse, Elizabeth Leroux, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 29, 2022
The Spanish-English bilingual experience and cognitive change in Hispanics/Latinos from the Hispanic Community Health Study/Study of Latinos-Investigation of Neurocognitive AgingMelissa Lamar, Wassim Tarraf, Benson Wu, et al.
Neurology|August 28, 2024
Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME TrialRichard B Lipton, Andrea M Harriott, Julia Y Ma, et al.
Headache|May 24, 2024
Machine learning identifies factors most associated with seeking medical care for migraine: Results of the OVERCOME (US) studySait Ashina, E Jolanda Muenzel, Robert A Nicholson, et al.
Cephalalgia : an International Journal of Headache|September 15, 2021
Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trialTodd J Schwedt, Richard B Lipton, Jessica Ailani, et al.
Headache|September 8, 2022
Short-term stroke risk after emergency department treat-and-release headache visitAva L Liberman, Cenai Zhang, Richard B Lipton, et al.
Cephalalgia : an International Journal of Headache|June 22, 2011
The International Burden of Migraine Study (IBMS): study design, methodology, and baseline cohort characteristicsKrista A Payne, Sepideh F Varon, Ariane K Kawata, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Reference Data of the Spanish Memory Binding Test in a Midlife Population from the ALFA STUDY (Alzheimer's and Family)Nina Gramunt, Herman Buschke, Gonzalo Sánchez-Benavides, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 1, 1992
Genetic, immunological, and metabolic determinants of risk for type 1 diabetes mellitus in familiesR B Lipton, J Atchison, J S Dorman, et al.
Pageof 118